Clinical investigations rarely place the same demands on every medical device company.
Some organisations have experienced internal clinical teams and need support only with a specific phase, such as monitoring or authority submissions. Others may need broader assistance with planning, site coordination, data quality, or study close-out. For smaller companies, the challenge may simply be having enough capacity to manage a clinical investigation alongside product development, regulatory work, and day-to-day operations.
For this reason, CRO support does not have to mean outsourcing an entire clinical investigation.
The right level of support depends on the study, the internal team, and where additional expertise or capacity creates the most value.
Before the clinical investigation begins
Some of the most important decisions are made before the first patient is enrolled.
A clinical investigation needs clear objectives, appropriate endpoints, realistic timelines, suitable sites, and documentation that supports both the study itself and the wider regulatory strategy.
At this stage, CRO involvement can help bring structure to the project. This may include supporting the development of the Clinical Investigation Plan, assessing feasibility, preparing study documentation, coordinating regulatory and ethics submissions, and helping identify suitable investigation sites.
Early support can also help ensure that the planned investigation generates evidence that is relevant to the device’s intended use and future regulatory needs.
This matters because clinical work is resource-intensive. If the study design, endpoints, or evidence strategy are not aligned from the beginning, correcting the direction later can be difficult and costly.
Getting the study ready to start
Once the study has been designed, the focus shifts toward making it operational.
Sites need to be activated, investigators and site personnel need the right information, monitoring activities need to be planned, and documentation needs to be in place before recruitment begins.
This phase involves a large amount of coordination between the sponsor, clinical sites, investigators, monitors, and other stakeholders.
CRO support can help manage these connections and ensure that responsibilities, timelines, and expectations are clear before the study moves into active recruitment.
For companies without a dedicated clinical operations function, this can be especially valuable. A technically strong development team may understand the device extremely well while still benefiting from additional experience in the practical management of clinical investigations.
During an active clinical investigation
Even a carefully planned study changes once it meets clinical reality.
Sites may recruit at different speeds. Questions arise during procedures. Protocol deviations occur. Documentation may require clarification, and data issues can emerge that need timely follow-up.
This is where project management and clinical monitoring become central.
Monitoring helps verify that the study is being conducted according to the protocol, applicable requirements, and the agreed study procedures. It also provides an important link between the sponsor and the investigation sites.
Strong project oversight brings these individual activities together. It helps track timelines, follow open issues, coordinate communication, and identify problems before they develop into larger delays.
CRO support during this stage can range from individual monitoring activities to broader study coordination and project management.
When the internal team needs additional capacity
Sometimes CRO support is needed not because a company lacks expertise, but because the existing team has too much happening at the same time.
Clinical investigations often overlap with technical documentation updates, regulatory submissions, product development, audits, fundraising, and other business-critical activities.
A temporary workload peak can place significant pressure on a small clinical or QA/RA team.
In these situations, an external CRO can take responsibility for clearly defined activities while continuing to work closely with the sponsor. This might include monitoring, study documentation, site communication, regulatory submissions, or specific project management tasks.
The objective is not to replace the internal team. It is to provide additional capacity where it is needed so that important clinical activities continue to move forward.
When a study needs an independent perspective
External support can also be useful when a clinical investigation is already underway.
A company may want an independent review of study documentation, monitoring practices, data quality, or overall project status. In other cases, recruitment may be slower than expected, deviations may be increasing, or unresolved site-level issues may be creating uncertainty.
Bringing in external clinical expertise can provide a fresh view of the project.
The value here is not necessarily taking over the investigation. It may simply be identifying where the main risks or bottlenecks are and helping the team establish a clearer path forward.
This kind of focused support can be particularly helpful when the internal team is deeply involved in the project and needs an outside perspective on whether the study is progressing as intended.
Closing the study and making the evidence usable
CRO involvement does not necessarily end when the last patient completes the investigation.
Study close-out, data review, final documentation, and reporting are important parts of ensuring that the work performed during the investigation can actually support future regulatory activities.
The resulting clinical evidence may feed into the Clinical Investigation Report, Clinical Evaluation Report, technical documentation, and future post-market clinical follow-up activities.
This makes the quality of study execution and documentation important well beyond the investigation itself.
Support during close-out can help ensure that outstanding issues are resolved, documentation is complete, and the evidence generated during the study can be used effectively in the next stages of the product lifecycle.
Choosing the right level of CRO support
There is no single point at which every medical device company should engage a CRO.
For one company, the greatest need may be early study planning and regulatory submissions. For another, it may be monitoring and site coordination during an ongoing investigation. A third may already have most capabilities internally but need additional support during a workload peak or help with study close-out.
The important question is not whether the entire clinical investigation should be outsourced.
It is where external clinical expertise can strengthen the project, reduce pressure on the internal team, and help maintain quality throughout the investigation.
A proportionate approach allows companies to use CRO support where it provides the most value while keeping sponsor oversight and decision-making within the organisation.
Supporting clinical investigations in practice
MDS supports medical device companies across different stages of clinical investigations, from early planning and documentation through study execution, monitoring, project management, and reporting.
Support can be tailored to a defined part of the investigation or provided across a broader clinical project depending on the company’s internal resources and needs.
The aim is to work alongside the sponsor and existing team, providing practical clinical expertise and additional capacity while helping keep the investigation structured, compliant, and focused on generating useful evidence.
If your team is planning a clinical investigation, managing an ongoing study, or needs additional CRO capacity for a specific phase, MDS can support your project with a practical and flexible approach.
You can contact us at Kristian@mdsdenmark.dk or via Book a Meeting.